logo

For the Inventor, By the Inventor

West Chester, OH, United States of America

Marion W Wannamaker

This inventor holds 6 USPTO granted patents, plus 5 CIPO patents. Top assignees: Merrell Dow Pharmaceuticals, Other. Active years: 1992-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marion W Wannamaker. Retrieved from https://idiyas.com/inventor/marion-w-wannamaker-u0dv8ykw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Cincinnati, OH (US) (1993 - 1994)
  • West Chester, OH (US) (1992 - 1996)

Company Filing History:

goldMedal5 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
silverMedal1 out of 834,570 
Other
 patents

Years Active: 1992-1996

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents
1. 5489600 - Piperidyl amides, sulfonamides and sulfoxamides as inhibitors of (1996-02-06),
2. 5350758 - Piperidyl sulfonamides and sulfoxamides as inhibitors of cholesterol (1994-09-27),
3. 5348964 - Piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis (1994-09-20),
4. 5278171 - Azadecalin amides and thioamides as inhibitors of cholesterol (1994-01-11),
5. 5217979 - Substituted alkyl piperidines (1993-06-08),
6. 5084461 - Azadecalin amides and thioamides as inhibitors of cholesterol (1992-01-28),

Title: Marion W Wannamaker: Innovator in Cholesterol Biosynthesis Inhibition

Introduction

Marion W Wannamaker is a notable inventor based in West Chester, OH (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cholesterol biosynthesis. With a total of 6 patents to her name, her work has had a meaningful impact on health and medicine.

Latest Patents

Among her latest patents are innovative compounds such as piperidyl amides, sulfonamides, and sulfoxamides. These compounds are recognized for their utility as inhibitors of cholesterol biosynthesis. Specifically, her invention of piperidyl amides is aimed at lowering total serum cholesterol in patients who require such treatment. Similarly, her piperidyl sulfonamides and sulfoxamides serve the same purpose, providing valuable options for managing cholesterol levels.

Career Highlights

Throughout her career, Marion has worked with reputable organizations, including Merrell Dow Pharmaceuticals. Her expertise in pharmaceutical innovation has positioned her as a key figure in the development of cholesterol-lowering agents.

Collaborations

Marion has collaborated with esteemed colleagues such as William R Moore and William A Van Sickle. These partnerships have further enhanced her research and development efforts in the pharmaceutical industry.

Conclusion

Marion W Wannamaker's contributions to the field of cholesterol biosynthesis inhibition exemplify her dedication to improving health outcomes. Her innovative patents and collaborations highlight her significant role in pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…